Collective Acquisition Corp II
CAIIW · NASDAQ
CAIIW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 3.07K
- Volume
- 39.37K
- Open price
- $0.1528
- High today
- $0.185
- Low today
- $0.1506
- 52 Week high
- $0.30
- 52 Week low
- $0.15
Collective Acquisition Corp II (CAIIW) at a glance
Collective Acquisition Corp II (CAIIW) last traded at $0.18, with a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.1506 and $0.185. The current price is 19.5% above the day's low and 2.7% below its high.
Volume so far is 39.37K shares, above the average of 3.07K shares a day.
Over the past year Collective Acquisition Corp II has ranged from $0.15 to $0.30, and now sits 20% of the way up that range.
Most active stocks
Highest trading volume today
- GTVHGolden Triangle Ventures$0.0001−50.00%
- BURUNuburu$0.3717+115.98%
- RDARRaadr$0.0002+0.00%
- WFFWF Holding$1.50+13.21%
- INLFINLIF$0.265+47.22%
- EARIEntertainment Arts Research$0.0002+0.00%
- ADTADT$9.87+33.20%
- AITXArtificial Intelligence Technology Solutions$0.0008+77.78%
- GOOGLAlphabet$283.82−12.64%
- NVDGraniteShares ETF Trust$4.09+2.00%
- INTCIntel$92.07−3.62%
- TIPSTianrong Internet Products & Services$0.0015+7.14%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.98+0.10%
- LYCALycia Therapeutics$27.73+10.70%
- DAVIDAVION HEALTHCARE$2.69−18.24%
- TCXBTCGX Acquisition Corp. II$10.21−0.61%
- CTYCITY THERAPEUTICS$22.14+2.26%
- IAMIambic Therapeutics$14.28−3.38%
- AMROAmaero$5.78−1.37%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.21−0.20%
- TRXBTRex Bio$13.52−6.31%
- RTSNRetension Pharmaceuticals$11.83−9.63%
- PAXGUPine Tree Acquisition$10.02−0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.